Application of magnetic-resonance-spectroscopy-based metabolomics to the fine-needle aspiration diagnosis of papillary thyroid carcinoma

Acta Cytologica

Volumn 55, Issue 6, 2011, Pages 584-589

  Jordan, Kate W ^a   Adkins, Christen B ^a   Cheng, Leo L ^a   Faquin, William C ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Diagnosis; Fine needle aspiration biopsy; Magnetic resonance spectroscopy; Metabolomics; Thyroid cancer

Indexed keywords

ARTICLE; ASPIRATION BIOPSY; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOLOGY; HISTOLOGY; HUMAN; HUMAN TISSUE; METABOLOMICS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PAPILLARY CARCINOMA; PAPILLARY THYROID CARCINOMA; PRIORITY JOURNAL; THYROID ADENOMA; THYROID CARCINOMA;

EID: 83455181367     PISSN: 00015547     EISSN: 19382650     Source Type: Journal    
DOI: 10.1159/000333271     Document Type: Article

References (22)

1. Hamberger B, Gharib H, Melton LJ 3rd, Goellner JR, Zinsmeister AR: Fine-needle aspiration biopsy of thyroid nodules: impact on thyroid practice and cost of care. Am J Med 1982; 73: 381-384. (Pubitemid 12031790)
2. Ravetto C, Colombo L, Dottorini ME: Usefulness of fine-needle aspiration in the diagnosis of thyroid carcinoma: a retrospective study in 37,895 patients. Cancer 2000; 90: 357-363. (Pubitemid 32011847)
3. Faquin WC: The thyroid gland: recurring problems in histologic and cytologic evaluation. Arch Pathol Lab Med 2008; 132: 622-632. (Pubitemid 351489616)
4. Renshaw AA: Accuracy of thyroid fine-needle aspiration using receiver operator characteristic curves. Am J Clin Pathol 2001; 116: 477-482. (Pubitemid 34450280)
5. Lewis CM, Chang KP, Pitman M, Faquin WC, Randolph GW: Thyroid fine-needle aspiration biopsy: variability in reporting. Thyroid 2009; 19: 717-723.
6. DeLellis R, Lloyd R, Heitz P, Eng C: World Health Organization Classification of Tumors: Tumours of Endocrine Organs. Lyon, IARC Press, 2004.
7. Stewart B, Kleihues P: World Cancer Report. Lyon, IARC Press, 2003.
8. Rosai J, Carcangiu M, DeLellis R: Atlas of Tumor Pathology: Tumors of the Thyroid Gland. Washington, Armed Forces Institute of Pathology, 1992.
9. Ali S, Cibas E: The Bethesda System for Reporting Thyroid Cytopathology. New York, Springer, 2010.
10. Ohori NP, Nikiforova MN, Schoedel KE, et al: Contribution of molecular testing to thyroid fine-needle aspiration cytology of 'follicular lesion of undetermined significance/atypia of undetermined significance'. Cancer Cytopathol 2010; 118: 17-23.
11. Nikiforova MN, Nikiforov YE: Molecular diagnostics and predictors in thyroid cancer. Thyroid 2009; 19: 1351-1361.
12. Cheng LL, Ma MJ, Becerra L, et al: Quantitative neuropathology by high resolution magic angle spinning proton magnetic resonance spectroscopy. Proc Natl Acad Sci USA 1997; 94: 6408-6413. (Pubitemid 27270698)
13. Cheng LL, Burns MA, Taylor JL, et al: Metabolic characterization of human prostate cancer with tissue magnetic resonance spectroscopy. Cancer Res 2005; 65: 3030-3034. (Pubitemid 40524579)
14. Cheng LL, Pohl U: The role of NMR-based metabolomics in cancer; in Lindon JC, Nicholls JK, Holmes E (eds): The Handbook of Metabonomics and Metabolomics. Amsterdam, Elsevier, 2007, pp 345-374.
15. King AD, Yeung DK, Ahuja AT, et al: In vivo 1H MR spectroscopy of thyroid carcinoma. Eur J Radiol 2005; 54: 112-117.
16. Gupta N, Kakar AK, Chowdhury V, Gulati P, Shankar LR, Vindal A: Magnetic resonance spectroscopy as a diagnostic modality for carcinoma thyroid. Eur J Radiol 2007; 64: 414-418. (Pubitemid 350116486)
17. Delbridge L, Lean C, Russell P, et al: Proton magnetic resonance and human thyroid neoplasia II: potential avoidance of surgery for benign follicular neoplasms. World J Surg 1994; 18: 512-517. (Pubitemid 24273849)
18. Lean C, Delbridge L, Russell P, et al: Diagnosis of follicular thyroid lesions by proton magnetic resonance on fine needle biopsy. J Clin Endocrinol Metab 1995; 80: 1306-1311.
19. Mackinnon WB, Delbridge L, Russell P, et al: Two-dimensional proton magnetic resonance spectroscopy for tissue characterization of thyroid neoplasms. World J Surg 1996; 20: 841-847. (Pubitemid 26281913)
20. Russell P, Lean C, Delbridge L, May G, Dowd S, Mountford CE: Proton magnetic resonance and human thyroid neoplasia. 1. Discrimination between benign and malignant follicular thyroid neoplasmas by magnetic resonance spectroscopy. Am J Med 1994; 96: 383-388. (Pubitemid 24127277)
21. Rutter A, Kunnecke B, Dowd S, Russell P, Delbridge L, Mountford CE: Proton magnetic resonance and human thyroid neoplasia. 3. Ex vivo chemical-shift microimaging. J Magn Reson B 1996; 110: 240-248. (Pubitemid 126758639)
22. Cheng LL, Lean CL, Bogdanova A, et al: Enhanced resolution of proton NMR spectra of malignant lymph nodes using magic-angle spinning. Magn Reson Med 1996; 36: 653-658. (Pubitemid 26376702)